Aurobindo Pharma (ARBP IN): Pain Continues in the U.S. Formulation Business
Aurobindo’s U.S. formulation business is witnessing price erosion, which is impacting the revenue and margin. However, value unlocking in...
307 Views
Event Update - ZyCoV-D vaccine approved in increasingly competitive domestic market - BUY
trial of the vaccine on 28,000 volunteers, including 1400 subjects in the age group of 12-17 age group. With favorable and acceptable safety...
114 Views
Event Update - ZyCoV-D vaccine approved in increasingly competitive domestic market - BUY
trial of the vaccine on 28,000 volunteers, including 1400 subjects in the age group of 12-17 age group. With favorable and acceptable safety...
141 Views
Cadila Health Care: Outlook Promising with Strong Pipeline
Cadila Healthcare is India's leading vertically integrated pharmaceutical company. With its presence across the value chain, it manufactures...
146 Views
Cadila Healthcare: Q3FY21 Earnings - Innovation in Focus
Cadila Healthcare reported its Q3FY21 earnings. Most promising aspect for Cadila is its focus on innovation that has been yielding good results...
211 Views